港股午評:恆科指大漲收復3600點 內房股與物管股飆漲
格隆匯11月14日丨港股上午盤三大指數繼續上漲行情,恆生科技指數漲3.54%,收復3600點關口,恆指、國指分別漲2.93%和3.4%。盤面上,大型科技股全線上漲帶動大市揚升,京東、百度漲超6%,網易漲超5%,小米、騰訊、美團皆走強;房地產支持政策紛至沓來,內房股與物管股暴力拉昇,龍光集團飆漲56%,碧桂園、時代中國控股、合景泰富均漲超40%,漲幅超10%個股多達20只;作爲房地產產業鏈股:建材水泥、重型機械、家居等集體活躍;醫藥類股持續拉昇,互聯網醫療股領漲,平安好醫生、阿里健康表現最佳。另一方面,在線教育股跌幅明顯,新東方下挫近10%,航空股、煤炭股、鋰電池普跌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.